美国BD采血管 蛋白组学采血管P800 366421 BD™ P800 Blood Collection System 366420

• Tube MaterialPlastic
• Tube Size16x100 mm
• Draw Volume8.5  mL
• Closure TypeBD Hemogard™
• Closure ColorClear
• LabelPaper
• Cell SeparatorNo
• AnticoagulantK₂EDTA
• AdditiveProprietary Cocktail of Protease, Esterase and DPP-IV Inhibitors
• SterilizationRadiation ,  10^-6 SAL ,  ISO11137-1

Description

BD™ P800 delivers enhanced accuracy in measuring plasma metabolic markers such as Glucagon-Like Peptide-1 (GLP-1), Glucagon, non-acyl Ghrelin, Gastric Inhibitory Polypeptide (GIP), and Oxyntomodulin (OXM) by stabilizing them at the point of collection.

BD™ P800 is an evacuated blood collection tube containing a proprietary cocktail of protease inhibitors, specifically optimized for stabilization of metabolic markers. The plasma obtained by processing the BD™ P800 tube can be used immediately, transported, or stored frozen.

BD™ P800 is for research use only – it is not for use in diagnostic procedures.

 

PREPARATION AND STORAGE

Store tubes at 2-8 ºC (≈39 ºF) unless otherwise noted on the package label. It is recommended to store the tubes in the original packaging until use.

1. Kishimoto M, Noda M. Effect of the Addition of Sitagliptin and Miglitolon Insulin-Treated Type 2 Diabetes. Diabetes Ther 2012;3:11.

2. Kishimoto M, Noda M. Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes. Diabetes Ther 2014;5:323–332.

3. Perala MM. Early Growth and Adult Health. Programming of postprandial responses, food intake and salt sensitivity. National Institute for Health and Welfare. Academic dissertation presented at the University of Helsinki, 2014.

4. Raines M, King C, Christensen S, Amin P, Schranz D. Glucagon Quantification: Comparison of Radioimmunoassay and Sandwich ELISA methods. Poster presented at the AACC, 2014.

5. Sloan JH, Siegel RW, Ivanova-Cox YT, Watson DE, et al. A novel high sensitivity electrochemiluminescence (ECL) sandwhich immunoassay for the specific quantitative measurement of plasma glucagon. Clin Biochem 2012;45:1640-1644.

6. Tatsoian DA, Guo Y, Schaeffer AK, Gaibu N, Popa S, et al. Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin. Diabetes Ther 2013;4:431-442.

7. Troutt JS, Siegel RW, Chen J, Sloan JH, Deeg MA, et al. Dual-Monoclonal, Sandwich Immunoassay Specific for Glucose-Dependent Insulinotropic Peptide1-42, the Active Form of the Incretin Hormone. Clin Chem 2011;57:849-855.

8. Yi J, Warunek D, Carft D. Degradation and Stabilization of Peptide Hormones in Human Blood Specimens. PLOS One 2015; 1-21.